Literature DB >> 99455

The effect of acetazolamide on cerebral blood flow and oxygen utilization in the rhesus monkey.

B E Laux, M E Raichle.   

Abstract

The brain is critically dependent for its moment to moment function and survival on an adequate supply of oxygen. The enzyme carbonic anhydrase (EC 4.2.1.1) may play an important role in oxygen delivery to brain tissue by facilitating the hydration of metabolically produced carbon dioxide in erythrocytes in brain capillaries, thus permitting the Bohr effect to occur. We examined the effect of 30 mg/kg i.v. acetazolamide, a potent inhibitor of carbonic anhydrase, upon cerebral blood flow and oxygen consumption in lightly anesthetized, passively ventilated rhesus monkeys. Cerebral blood flow and oxygen consumption were measured with oxygen-15-labeled water and oxygen-15-labeled oxyhemoglobin, respectively, injected into the internal carotid artery and monitored externally. Acetazolamide produced an immediate and significant increase in cerebral blood flow (from a mean of 64.7 to 83.8 ml/100 g per min), an increase in arterial carbon dioxide tension (from a mean of 40.7 to 47.5 torr), and a decrease in cerebral oxygen consumption (from a mean of 4.16 to 2.82 ml/100 g per min). Because the change in cerebral oxygen consumption occurred within minutes of the administration of acetazolamide, we believe that this effect probably was not due to a direct action on brain cells but was achieved by an interference with oxygen unloading in brain capillaries. A resultant tissue hypoxia might well explain part of the observed increase in cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99455      PMCID: PMC371803          DOI: 10.1172/JCI109164

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  ARTERIAL PCO2 AND CEREBRAL HEMODYNAMICS.

Authors:  M REIVICH
Journal:  Am J Physiol       Date:  1964-01

2.  HUMAN CEREBROVASCULAR RESPONSE TIME TO ELEVATION OF ARTERIAL CARBON DIOXIDE TENSION.

Authors:  E SHAPIRO; A J WASSERMAN; J L PATTERSON
Journal:  Arch Neurol       Date:  1965-08

3.  A kinetic analysis of carbonic anhydrase inhibition.

Authors:  T H MAREN; A L PARCELL; M N MALIK
Journal:  J Pharmacol Exp Ther       Date:  1960-12       Impact factor: 4.030

4.  Interaction of cerebral hemodynamics and metabolism.

Authors:  J S MEYER; F GOTOH
Journal:  Neurology       Date:  1961-04       Impact factor: 9.910

5.  Inhibition of carbonic anhydrase: its effect on carbon dioxide elimination by the lungs.

Authors:  J C MITHOEFER
Journal:  J Appl Physiol       Date:  1959-01       Impact factor: 3.531

6.  Sulfur-35 labeled acetazolamide in cat brain.

Authors:  L J ROTH; J C SCHOOLAR; C F BARLOW
Journal:  J Pharmacol Exp Ther       Date:  1959-02       Impact factor: 4.030

7.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy.

Authors:  J B POSNER; F PLUM
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

Review 8.  Use of inhibitors in physiological studies of carbonic anhydrase.

Authors:  T H Maren
Journal:  Am J Physiol       Date:  1977-04

9.  Time course of exchanges between red cells and extracellular fluid during CO2 uptake.

Authors:  R E Forster; E D Crandall
Journal:  J Appl Physiol       Date:  1975-04       Impact factor: 3.531

10.  Preparation of short half-lived radioactive gases for medical studies.

Authors:  M J Welch; M M Ter-Pogossian
Journal:  Radiat Res       Date:  1968-12       Impact factor: 2.841

View more
  20 in total

1.  Body fluid status on induction, reinduction and prolonged stay at high altitude of human volunteers.

Authors:  M V Singh; S B Rawal; A K Tyagi
Journal:  Int J Biometeorol       Date:  1990-08       Impact factor: 3.787

2.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

3.  Comparative study of acetazolamide and spironolactone on body fluid compartments on induction to high altitude.

Authors:  M V Singh; S C Jain; S B Rawal; H M Divekar; R Parshad; A K Tyagi; K C Sinha
Journal:  Int J Biometeorol       Date:  1986-03       Impact factor: 3.787

4.  Human non-REM sleep and the mean global BOLD signal.

Authors:  Mark P McAvoy; Enzo Tagliazucchi; Helmut Laufs; Marcus E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-03       Impact factor: 6.200

5.  Amelioration of acute mountain sickness: comparative study of acetazolamide and spironolactone.

Authors:  S C Jain; M V Singh; V M Sharma; S B Rawal; A K Tyagi
Journal:  Int J Biometeorol       Date:  1986-12       Impact factor: 3.787

6.  Changes in body fluid compartments on re-induction to high altitude and effect of diuretics.

Authors:  M V Singh; S B Rawal; A K Tyagi; J K Bhagat; R Parshad; H M Divekar
Journal:  Int J Biometeorol       Date:  1988-04       Impact factor: 3.787

7.  Cerebral hemodynamics and "re-build-up" phenomenon on electroencephalogram in children with moyamoya disease.

Authors:  S Kuroda; H Kamiyama; M Isobe; K Houkin; H Abe; K Mitsumori
Journal:  Childs Nerv Syst       Date:  1995-04       Impact factor: 1.475

8.  The effects of acetazolamide and spironolactone on the body water distribution of rabbits during acute exposure to simulated altitude.

Authors:  S C Jain; M V Singh; S B Rawal
Journal:  Int J Biometeorol       Date:  1984-05       Impact factor: 3.787

9.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26

10.  Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen.

Authors:  S Vorstrup; L Henriksen; O B Paulson
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.